LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Effect of differentiated direct-to-pharmacy PrEP refill visits supported with client HIV self-testing on clinic visit time and early PrEP continuation.

Zewdie, Kidist Belay / Ngure, Kenneth / Mwangi, Margaret / Mwangi, Dominic / Maina, Simon / Etyang, Lydia / Maina, Gakuo / Ogello, Vallery / Owidi, Emmah / Mugo, Nelly R / Baeten, Jared M / Mugwanya, Kenneth K

Journal of the International AIDS Society

2024  Volume 27, Issue 3, Page(s) e26222

Abstract: Introduction: Delivery of oral pre-exposure prophylaxis (PrEP) is being scaled up in Africa, but clinic-level barriers including lengthy clinic visits may threaten client continuation on PrEP.: Methods: Between January 2020 and January 2022, we ... ...

Abstract Introduction: Delivery of oral pre-exposure prophylaxis (PrEP) is being scaled up in Africa, but clinic-level barriers including lengthy clinic visits may threaten client continuation on PrEP.
Methods: Between January 2020 and January 2022, we conducted a quasi-experimental evaluation of differentiated direct-to-pharmacy PrEP refill visits at four public health HIV clinics in Kenya. Two clinics implemented the intervention package, which included direct-to-pharmacy for PrEP refill, client HIV self-testing (HIVST), client navigator, and pharmacist-led rapid risk assessment and dispensing. Two other clinics with comparable size and client volume served as contemporaneous controls with the usual clinic flow. PrEP continuation was evaluated by visit attendance and pharmacy refill records, and time and motion studies were conducted to determine time spent in the clinics. Dried blood spots were collected to test for tenofovir-diphosphate (TFV-DP) at random visits. We used logistic regression to assess the intervention effect on PrEP continuation and the Wilcoxon rank sum test to assess the effect on clinic time.
Results: Overall, 746 clients were enrolled, 366 at control clinics (76 during pre-implementation and 290 during implementation phase), and 380 at direct-to-pharmacy clinics (116 during pre-implementation and 264 during implementation phase). Prior to implementation, the intervention and control clinics were comparable on client characteristics (female: 51% vs. 47%; median age: 33 vs. 33 years) and PrEP continuation (35% vs. 37% at 1 month, and 37% vs. 39% at 3 months). The intervention reduced total time spent at the clinic by 35% (median of 51 minutes at control vs. 33 minutes at intervention clinics; p<0.001), while time spent on HIV testing (20 vs. 20 minutes; p = 0.50) and pharmacy (8 vs. 8 minutes; p = 0.8) was unchanged. PrEP continuation was higher at intervention versus the control clinics: 45% versus 33% at month 1, 34% versus 25% at month 3 and 23% versus 16% at month 6. TFV-DP was detected in 85% (61/72) of samples, similar by the study group (83% vs. 85%).
Conclusions: A client-centred PrEP delivery approach with direct-to-pharmacy PrEP refill visits plus client HIVST significantly reduced clinic visit time by more than one-third and improved PrEP continuation in public health HIV clinics in Kenya.
MeSH term(s) Adult ; Female ; Humans ; Adenine/analogs & derivatives ; Ambulatory Care ; HIV ; HIV Infections/diagnosis ; HIV Infections/drug therapy ; HIV Infections/prevention & control ; HIV Testing ; Kenya ; Organophosphates ; Pharmacy ; Self-Testing ; Male
Chemical Substances Adenine (JAC85A2161) ; Organophosphates ; tenofovir diphosphate
Language English
Publishing date 2024-03-06
Publishing country Switzerland
Document type Journal Article
ZDB-ID 2467110-1
ISSN 1758-2652 ; 1758-2652
ISSN (online) 1758-2652
ISSN 1758-2652
DOI 10.1002/jia2.26222
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top